One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Biosurgery Market

[ 英語タイトル ] Biosurgery Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0084194
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 114
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Baxter International, Inc.
- B.Braun Melsungen AG
- Becton, Dickinson and Company (C.R. Bard)
- Johnson & Johnson
- Medtronic, PLC.
- MAQUET Holding B.V. & Co. Kg. (Getinge Group)
- Cohera Medical Inc.
- Integra Lifesciences Holdings Corporation
- Commonwealth Serum Laboratories (CSL)
- Hemostasis, LLC
- CryoLife, Inc.

[Report Description]

The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products.

The global increase in the number of geriatrics population and obese people is likely to lead to numerous health consequences, like greater incidences of ortho and neuro problems. Consequently, the geriatric population and population with obesity are at a higher risk of multiple disorders and diseases.

According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in the geriatric and obese population is acting as a major driver for the growth of the biosurgery market.

Key Market Trends

Neurology Segment is Expected to Grow with Good CAGR in the Application Segment

Neurology and spine-related surgery applications of biosurgery are the major market segments and their growth is driven by a mainly wide application of bone graft substitute products in different biosurgery processes.

Another major application segment of biosurgery is the cardiovascular surgery segment that is expected to grow with a positive CAGR in the forecast period, and factors such as the increasing number of cardiac problems in the people across the globe are augmenting the market growth.

North America is Expected to Dominates the Market in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing number of surgeries, rising obese patients, and increasing geriatric population.

In the North America region, the United States holds the largest market share due to factors such as increasing count of geriatrics, along with the growing healthcare industry, which is anticipated to stimulate the demand in this region. Substantial investments by governments to strengthen public healthcare delivery is a key factor augmenting the growth of the market.

Competitive Landscape

The biosurgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population
4.2.2 Rising Prevalence of Chronic Diseases and Related Surgeries
4.2.3 Strong Focus on R&D Leading to the Launch of New and Advanced Products
4.3 Market Restraints
4.3.1 High Price of Biosurgery Products and Rising Cost of Surgical Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Bone-Graft Substitutes
5.1.2 Soft-Tissue Attachments
5.1.3 Hemostatic Agents
5.1.4 Surgical Sealants and Adhesives
5.1.5 Adhesion Barriers
5.1.6 Others
5.2 By Application
5.2.1 Orthopedic Surgery
5.2.2 General Surgery
5.2.3 Neurological Surgery
5.2.4 Cardiovascular Surgery
5.2.5 Gynecological Surgery
5.2.6 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Baxter International, Inc.
6.1.2 B.Braun Melsungen AG
6.1.3 Becton, Dickinson and Company (C.R. Bard)
6.1.4 Johnson & Johnson
6.1.5 Medtronic, PLC.
6.1.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
6.1.7 Cohera Medical Inc.
6.1.8 Integra Lifesciences Holdings Corporation
6.1.9 Commonwealth Serum Laboratories (CSL)
6.1.10 Hemostasis, LLC
6.1.11 CryoLife, Inc.




Recommended reports